Copyright 1993 The Times Mirror Company Los Angeles Times August 26, 1993, Thursday, Home Edition Correction Appended LANGUAGE: ENGLISH LOAD-DATE-MDC: August 27, 1993 SECTION: Part A; Page 15; Column 1; National Desk LENGTH: 637 words HEADLINE: FDA ADVISERS OK HUMAN TESTING OF HALLUCINOGEN; HEALTH: SUPPORTERS SAY IBOGAINE MAY HELP SOME…
Copyright Manisses Communications Group 1993 Alcoholism & Drug Abuse Week July 12, 1993 CLASS: Trade & Industry LANGUAGE: ENGLISH LOAD-DATE-MDX: January 13, 1994 SECTION: Vol. 5 ; No. 28 ; Pg. 5; ISSN: 1042-1394 LENGTH: 191 words HEADLINE: Ibogaine found toxic in lab tests. BODY: Ibogaine someday could be used…
Copyright 1992 Newsday, Inc. Newsday November 19, 1992, Thursday, NASSAU AND SUFFOLK EDITION SECTION: PART II; ADDICTION & OBSESSION; Pg. 68 Other Edition: City Pg. 72 LENGTH: 4505 words HEADLINE: Howard Lotsof insists he has the cure for drug addiction. Some authorities are beginning to take him seriously. BYLINE: By…
Copyright 1992 Globe Newspaper Company The Boston Globe November 9, 1992, Monday, City Edition SECTION: SCIENCE & TECHNOLOGY; Pg. 29 LENGTH: 1371 words HEADLINE: HALLUCINOGEN BEING STUDIED AS TREATMENT FOR ADDICTION; PHARMACOLOGY BYLINE: By Dolores Kong, Globe Staff BODY: In the urgent search for new treatments for cocaine and heroin…
PSYCHEDELIC SCIENCE – Documentary by Bill Eagles Aired on: February 27th, 1997, BBC NARRATOR (HUGH QUARSHIE): Controversial human experiments with the psychedelic drug LSD held new promise for psychiatry in the 1950s. They were closed down when the drug was made illegal in 1966. Today a new generation of American scientists…
NCTR 2002-2003 Research Plans – Neurotoxicology Title: Effects of Ibogaine on Neurotransmitter Systems, Generation of Free Radicals and Nitric Oxide Synthase Activity: Correlation with Neurohistological Evaluations in Mouse and Rat Brain Determine the effects of ibogaine on dopamine, serotonin and their metabolite concentrations in different regions of mouse and rat…
Ibogaine Patents @ the United States Patent Office (USPO) Use of ibogaine in reducing excitotoxic brain damage Use of ibogaine in reducing excitotoxic brain damage This invention discloses that ibogaine, a plant derivative, can be used as a safe NMDA antagonist at relatively high dosages (including dosages high enough to…
18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18-MC…
The San Francisco Ibogaine Forum New Directions in Treatment Friday, Nov. 29th | (Reception 6:00 – 9:00 pm – TBA) Saturday, Nov. 30th | (Forum 9:00 am – 6:00 pm) First Unitarian Universalist Church & Center 1187 Franklin St. (at Geary Blvd.) San Francisco, CA 94109 (Thomas Starr King…
Paris International Ibogaine Conference Friday, December 6, 2002 L’Espace 3 Rue de la Chappelle (tel, 01133140373928) 60 Euro admission Contact: F. Ghehioueche (011 33-614-815-679) A.M. Angel (011 33-612-936-958) Presenters / Participants [09:00 AM] Introduction – Dr. Bertrand LeBeau Introduction par le docteur Bertrand LeBeau [09:30 AM] On the Bwiti –…